SPARC mRNA Expression as a Prognostic Marker for Pancreatic Adenocarcinoma Patients

被引:0
作者
Miyoshi, Kei [1 ]
Sato, Norihiro [2 ]
Ohuchida, Kenoki [1 ]
Mizumoto, Kazuhiro [1 ]
Tanaka, Masao [1 ]
机构
[1] Kyushu Univ, Dept Surg & Oncol, Grad Sch Med Sci, Fukuoka 8128582, Japan
[2] Kyushu Univ, Dept Canc Therapy & Res, Grad Sch Med Sci, Fukuoka 8128582, Japan
关键词
SPARC; pancreatic cancer; prognosis; TUMOR-STROMAL INTERACTIONS; BREAST-CANCER; GENE-EXPRESSION; POOR-PROGNOSIS; OSTEONECTIN; INVASION; PROTEIN; CELLS; OVEREXPRESSION; CARCINOMA;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Secreted protein acidic and rich in cysteine (SPARC) is a protein which governs diverse cellular functions and matrix remodeling systems. It was reported that SPARC expression of peritumoral fibroblasts was correlated with poor prognosis in resectable pancreatic cancer patients in immunohistochemical analysis. However, the significance of SPARC mRNA expression in pancreatic adenocarcinoma remains unclear. Materials and Methods: SPARC mRNA expression was evaluated in 104 formalin-fixed paraffin-embedded tissue samples of pancreatic adenocarcinoma patients with macro-dissection technique. Results: High SPARC mRNA expression was associated with a poorer prognosis than low SPARC. In univariate Cox's proportion hazard model, depth of tumor invasion, lymph node metastasis, histopathological tumor grade, lymphatic invasion, vascular invasion, surgical margin, no chemotherapy and high SPARC expression were significant prognostic factors. In multivariate analysis, histopathological tumor grade, surgical margin, no chemotherapy and high SPARC expression were independent significant prognostic factors. Conclusion: SPARC mRNA expression is a prognostic marker for pancreatic adenocarcinoma patients.
引用
收藏
页码:867 / 871
页数:5
相关论文
共 31 条
[1]  
[Anonymous], 2002, AJCC cancer staging manual, V6th, P157
[2]  
[Anonymous], 2013, International Classification of disease for Oncology
[3]   Stromal osteonectin overexpression is associated with poor outcome in patients with ampullary cancer [J].
Bloomston, Mark ;
Ellison, E. Christopher ;
Muscarella, Peter ;
Al-Saif, Osama ;
Martin, Edward W. ;
Melvin, W. Scott ;
Frankel, Wendy L. .
ANNALS OF SURGICAL ONCOLOGY, 2007, 14 (01) :211-217
[4]   SPARC, a matricellular protein that functions in cellular differentiation and tissue response to injury [J].
Bradshaw, AD ;
Sage, EH .
JOURNAL OF CLINICAL INVESTIGATION, 2001, 107 (09) :1049-1054
[5]   TREATMENT AND SURVIVAL IN 13560 PATIENTS WITH PANCREATIC-CANCER, AND INCIDENCE OF THE DISEASE, IN THE WEST MIDLANDS - AN EPIDEMIOLOGIC-STUDY [J].
BRAMHALL, SR ;
ALLUM, WH ;
JONES, AG ;
ALLWOOD, A ;
CUMMINS, C ;
NEOPTOLEMOS, JP .
BRITISH JOURNAL OF SURGERY, 1995, 82 (01) :111-115
[6]   Enhanced growth of tumors in SPARC null mice is associated with changes the ECM [J].
Brekken, RA ;
Puolakkainen, P ;
Graves, DC ;
Workman, G ;
Lubkin, SR ;
Sage, EH .
JOURNAL OF CLINICAL INVESTIGATION, 2003, 111 (04) :487-495
[7]   Transcriptional upregulation of SPARC, in response to c-Jun overexpression, contributes to increased motility and invasion of MCF7 breast cancer cells [J].
Briggs, J ;
Chamboredon, S ;
Castellazzi, M ;
Kerry, JA ;
Bos, TJ .
ONCOGENE, 2002, 21 (46) :7077-7091
[8]   Novel markers for poor prognosis in head and neck cancer [J].
Chin, D ;
Boyle, GM ;
Williams, RM ;
Ferguson, K ;
Pandeya, N ;
Pedley, J ;
Campbell, CM ;
Theile, DR ;
Parsons, PG ;
Coman, WB .
INTERNATIONAL JOURNAL OF CANCER, 2005, 113 (05) :789-797
[9]   Osteonectin influences growth and invasion of pancreatic cancer cells [J].
Guweidhi, A ;
Kleeff, J ;
Adwan, H ;
Giese, NA ;
Wente, MN ;
Giese, T ;
Büchler, MW ;
Berger, MR ;
Friess, H .
ANNALS OF SURGERY, 2005, 242 (02) :224-234
[10]   High expression of HIF1a is a predictor of clinical outcome in patients with pancreatic ductal adenocarcinomas and correlated to PDGFA, VEGF, and bFGF [J].
Hoffmann, Andreas-Claudius ;
Mori, Ryutaro ;
Vallbohmer, Daniel ;
Brabender, Jan ;
Klein, Ellen ;
Drebber, Uta ;
Baldus, Stephan E. ;
Cooc, Janine ;
Azuma, Mizutomo ;
Metzger, Ralf ;
Holscher, Arnulf H. ;
Danenberg, Kathleen D. ;
Prenzel, Klaus L. ;
Danenberg, Peter V. .
NEOPLASIA, 2008, 10 (07) :674-679